CVS Health Corporation Common Stock (CVS)
Stock · NYSE · Consumer Staples
$93.06as of 8/28/2026
Price chart
Open in TradingViewActive signals
Support level
$74.77
Industry
Retail-Drug Stores and Proprietary Stores
About CVS
CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care managemen…
- Sector
- Consumer Staples
- Industry
- Retail-Drug Stores and Proprietary Stores
- Employees
- 219,000
- Website
- cvshealth.com/
Fundamentals
- 1-day range
- $93.02$93.93
- Market cap
- $134.44B
- P/E (trailing)
- 25.04
- P/E (forward)
- 10.94
- EPS (trailing)
- $3.77
- Dividend yield
- 3.49%
- Beta
- 0.58
- Avg. volume
- 7.99M
- Ex-dividend date
- July 23, 2026
- Dividend pay date
- August 3, 2026
52-week range
$69.51$110.68
Next earnings: October 28, 2026 · EPS estimate $1.63Before Openconfirmed
How CVS Health Corporation Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 10, 2026 · via SEC EDGAR / Finnhub
Forecasts
25 analyst ratings
Buy 85%
Hold 15%
Sell 0%
1-year price forecast
High
$148
+59.0%
Median
$116
+24.7%
Low
$103
+10.7%
CVS Health Corporation Common Stock Competitors
Chosen by industry and closest market cap.
- CVSCVS Health Corporation Common Stock$93.07▲ 0.16%Market cap $134.44BP/E 25.04$69.51$110.68
- GRDNGuardian Pharmacy Services Inc. Class A Common Stock$37.09▼ 0.64%Market cap $2.58BP/E 45.91$23.14$47.02
- PETSPetMed Express Inc. Common Stock$1.88▲ 1.35%Market cap $42.32MP/E —$1.57$4.1
- YI111 Inc. American Depositary Shares$3.46▼ 1.14%Market cap $31.82MP/E —$2.48$11.17
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| CVS CVS Health Corporation Common Stock | $134.44B | 25.04 | $93.07 | ▲ 0.16% | $69.51$110.68 |
| GRDN Guardian Pharmacy Services Inc. Class A Common Stock | $2.58B | 45.91 | $37.09 | ▼ 0.64% | $23.14$47.02 |
| PETS PetMed Express Inc. Common Stock | $42.32M | — | $1.88 | ▲ 1.35% | $1.57$4.1 |
| YI 111 Inc. American Depositary Shares | $31.82M | — | $3.46 | ▼ 1.14% | $2.48$11.17 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Walmart Agrees to $50 Million Settlement With DOJ Over Alleged Opioid Prescription Violations, Calls Payout ‘Immaterial’benzinga · 8/29/2026
- Walmart Agrees to $50 Million Settlement With DOJ Over Alleged Opioid Prescription Violations, Calls Payout ‘Immaterial’Benzinga · 8/29/2026
- CVS Health: Discounted, Vertically Integrated Healthcare Winner - Richer Returns AheadSeekingAlpha · 8/24/2026
- CVS Health Stock Is Beating the Market in 2026. Here's Why Wall Street Thinks It Can Soar Another 22%.Yahoo · 8/22/2026
- Is The Pullback In UNH Stock A Glitch Or A Warning?Yahoo · 8/21/2026
- Mark Cuban: “No Chance” Radiologists Get Replaced by AI. He Says the Real Target Is ElsewhereYahoo · 8/21/2026
- CVS Health: Every Community Deserves a Healthier HeartYahoo · 8/21/2026
- Hims & Hers Health Stock Trades Below The Market On Revenue And Above It On CashYahoo · 8/20/2026
- Temporary Mobile CVS Pharmacy Helps Restore Pharmacy Access in Pawling, NY, Following FireYahoo · 8/20/2026
Insider Activity
Insider Actions →Acquired
4.4K
Disposed
3.79M
- Brian Newman · May 31, 2026 · Tax Withholding2.5K @ $90.98
- Amy Compton-Phillips · May 31, 2026 · Tax Withholding7.6K @ $90.98
- Fernando Aguirre · May 21, 2026 · Disposition1.6K @ $93.5
- Larry Robbins · May 21, 2026 · Sale378.0K @ $93.31
- Larry Robbins · May 21, 2026 · Sale370.5K @ $93.45
- Fernando Aguirre · May 20, 2026 · Disposition30.4K @ $93.78
- Larry Robbins · May 20, 2026 · Sale800 @ $96.28
- Larry Robbins · May 20, 2026 · Sale66.9K @ $95.67
- Larry Robbins · May 20, 2026 · Sale152.7K @ $94.81
- Larry Robbins · May 20, 2026 · Sale797.6K @ $93.48
- Larry Robbins · May 19, 2026 · Sale151 @ $95.18
- Larry Robbins · May 19, 2026 · Sale1.98M @ $94.45
- Finucane Anne A. · May 14, 2026 · Grant1.5K @ $97.15
- Guy P. Sansone · May 14, 2026 · Grant1.4K @ $97.15
- DECOUDREAUX ALECIA A · May 14, 2026 · Grant1.4K @ $97.15
Institutional Ownership
March 31, 2026
- Total shares held
- 1.06B
- Total value held
- $73.07B
- Institutional holders
- 1850
Top holders this quarter
- Unknown125.92M
- Unknown82.65M
- Unknown77.25M
- Unknown59.32M
- Unknown51.78M
- Unknown31.20M
- Unknown29.46M
- Unknown25.14M
- Unknown23.78M
- Unknown22.57M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedSynthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
August 30, 2026
CVS in Spotlight as Walmart Settles DOJ Opioid Case. A recent DOJ settlement saw Walmart agree to pay $50 million over alleged opioid prescription violations, calling the payout immaterial. The case highlights continued regulatory scrutiny on how large retailers and pharmacies handle controlled substances, an area where CVS Health also operates. Separately, a Seeking Alpha analysis frames CVS as a discounted, vertically integrated healthcare player with potential for stronger returns ahead. Together, these stories keep CVS in focus around both regulatory risk in its pharmacy business and its broader positioning in healthcare delivery.